Melola Discovery

← Melola Discovery

Journal SINTA 1

EFFECT OF G-CSF ON ANC LEVEL IN ALL (Acute Lymphoblastic Leukemia) PATIENT WITH NEUTROPENIA AND FEBRILE NEUTROPENIA DURING CHEMOTHERAPY

Folia Medica Indonesiana · Vol. 50 No. 3 (2014)

ISSN
2355-8393, 2599-056X
Published
2014-07-01
Publisher
Airlangga University
Language
en

Abstract

Acute Lymphoblastic Leukemia (ALL) is the most common malignancy in children. Chemotherapy-induced neutropenia (CIN) is oneof the serious adverse events that may cause complication such as febrile neutropenia. Neutrophils level is increased using G-CSF,whose effectiveness based on ANC (absolute neutrophil counts) pre and post G-CSF therapy level remains unknown. This study wasto analyze the ANC level changes pre and post G-CSF therapy in neutropenia and febrile neutropenia patients with standard risk andhigh risk chemotherapy protocol. This was a retrospective-observational study from January 2010 to December 2013. Pre-therapyANC level had been collected before receiving G-CSF therapy. Post-therapy ANC level was collected between day 1 to 7 aftertherapy discontinuation. Data were analyzed using paired t-test to determine ANC level changes pre- and post-therapy. Range of GCSFdose of neutropenia vs febrile neutropenia patient with SR protocols therapy was 9.172 ± 1.5646 vs 9.079 ± 1.646 μg/kgBW,and for HR protocols 9.909 ± 1.1229 vs 9.114 ± 1.8551 μg/kgBW/day. In conclusion, G-CSF in a dose of 5-10 μg/kgBW per dayincreases ANC level significantly in ALL patients with neutropenia under high risk and standard risk protocol and in ALL patientswith febrile neutropenia under standard risk protocol. However, the increase of ANC level is not significant in ALL patients withfebrile neutropenia under high risk protocol. (FMI 2014;50 179-186)

Keywords

Collaboration network of the authors

31 authors · 63 co-authorship links · 18 across different organisations

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Poltekkes Kemenkes Malang
  • Universitas Airlangga
  • Rumah Sakit Dokter Soetomo
  • Universitas Pesantren Tinggi Darul Ulum Jombang
  • State University of Semarang
  • RSUD Prof. Dr. Saiful Anwar Malang
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Yulistiani YulistianiUniversitas Airlangga4
Siti MuafifahState University of Semarang2
Erliyah Nurul JannahUniversitas Pesantren Tinggi Darul Ulum Jombang1
Mukhammad MasrurUniversitas Pesantren Tinggi Darul Ulum Jombang1
Kerent Thania DadhinastitiePoltekkes Kemenkes Malang1
WandiPoltekkes Kemenkes Malang1
Cholifa Arika WardaniPoltekkes Kemenkes Malang1
Handy LalaPoltekkes Kemenkes Malang1
Fiashriel LundyPoltekkes Kemenkes Malang1
Rena Aanisah Dhiyaa' PermataPoltekkes Kemenkes Malang1
Octaviana Maria SimbolonUniversitas Airlangga1
I Dg UgrasenaUniversitas Airlangga1
Nun ZairinaRumah Sakit Dokter Soetomo1
Febriansyah Nur UtomoRumah Sakit Dokter Soetomo1
Mia Ratwita AndarsiniUniversitas Airlangga1
Levana RismayantiUniversitas Airlangga1
Bagus Putu Putra SuryanaRSUD Prof. Dr. Saiful Anwar Malang1
Hendera HenderaAffiliation unknown1
Dessy Surya SetyaniUniversitas Airlangga1
Ninik AsmaningsihRumah Sakit Dokter Soetomo1
I Dewa Gede UgrasenaUniversitas Airlangga1
Edy SupriadiAffiliation unknown1
Laura VrolingAffiliation unknown1
Jacqueline J CloosAffiliation unknown1
Muhammad YahyaRumah Sakit Dokter Soetomo1
SuhatnoAffiliation unknown1
Elisabeth KasihAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">EFFECT OF G-CSF ON ANC LEVEL IN ALL (Acute Lymphoblastic Leukemia) PATIENT WITH NEUTROPENIA AND FEBRILE NEUTROPENIA DURING CHEMOTHERAPY</dc:title><dc:creator>Siti Asiyah</dc:creator><dc:creator>Bambang Permono</dc:creator><dc:creator>Yulistiani Yulistiani</dc:creator><dc:creator>Mariyatul Qibtiyah</dc:creator><dc:subject>granulocyte colony-stimulating factor</dc:subject><dc:subject>acute lymphoblastic leukemia</dc:subject><dc:subject>febrile neutropenia</dc:subject><dc:subject>chemotherapy-induced neutropenia</dc:subject><dc:subject>absolute neutrophil count</dc:subject><dc:subject>pediatric leukemia</dc:subject><dc:description xml:lang="en">Acute Lymphoblastic Leukemia (ALL) is the most common malignancy in children. Chemotherapy-induced neutropenia (CIN) is oneof the serious adverse events that may cause complication such as febrile neutropenia. Neutrophils level is increased using G-CSF,whose effectiveness based on ANC (absolute neutrophil counts) pre and post G-CSF therapy level remains unknown. This study wasto analyze the ANC level changes pre and post G-CSF therapy in neutropenia and febrile neutropenia patients with standard risk andhigh risk chemotherapy protocol. This was a retrospective-observational study from January 2010 to December 2013. Pre-therapyANC level had been collected before receiving G-CSF therapy. Post-therapy ANC level was collected between day 1 to 7 aftertherapy discontinuation. Data were analyzed using paired t-test to determine ANC level changes pre- and post-therapy. Range of GCSFdose of neutropenia vs febrile neutropenia patient with SR protocols therapy was 9.172 ± 1.5646 vs 9.079 ± 1.646 μg/kgBW,and for HR protocols 9.909 ± 1.1229 vs 9.114 ± 1.8551 μg/kgBW/day. In conclusion, G-CSF in a dose of 5-10 μg/kgBW per dayincreases ANC level significantly in ALL patients with neutropenia under high risk and standard risk protocol and in ALL patientswith febrile neutropenia under standard risk protocol. However, the increase of ANC level is not significant in ALL patients withfebrile neutropenia under high risk protocol. (FMI 2014;50 179-186)</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2014-07-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>http://journal.unair.ac.id/FMI@effect-of-g-csf-on-anc-level-in-all-(acute-lymphoblastic-leukemia)-patient-with-neutropenia-and-febrile-neutropenia-during-chemotherapy-article-9248-media-3-category-3.html</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 50 No 3 (2014)</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language></oai_dc:dc>